Investigating how a specific enzyme can help improve energy production in cells with mitochondrial issues

NAD(P)H quinone oxidoreductase 1 (NQO1)-mediated bypass of mitochondrial electron transport chain with artificial and endogenous substrates

NIH-funded research Scintillon Institute for Photobiology · NIH-10789749

This study is looking at how a specific enzyme called NQO1 can help cells produce energy when their usual energy-making process isn't working well, which could lead to new treatments for conditions related to mitochondrial problems.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionScintillon Institute for Photobiology NIH-funded
Lab location1 site (San Diego, United States)
Project IDNIH-10789749 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) in bypassing the mitochondrial electron transport chain, which is crucial for energy production in cells. By identifying both artificial and natural substrates that can be processed by NQO1, the study aims to restore balance in cellular energy metabolism, particularly in conditions where mitochondrial dysfunction is present. The approach involves using advanced metabolomic profiling techniques to discover how this enzyme interacts with various metabolites, potentially leading to new therapeutic strategies for diseases linked to mitochondrial issues.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with known mitochondrial dysfunction or related metabolic disorders.

Not a fit: Patients without mitochondrial dysfunction or those not experiencing related metabolic issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve energy production in patients with mitochondrial dysfunction, potentially alleviating symptoms and improving quality of life.

How similar studies have performed: While the specific approach of using NQO1-mediated electron transfer is novel, similar strategies targeting mitochondrial dysfunction have shown promise in other research.

Where this research is happening

San Diego, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.